Chronic immune activation and inflammation as the cause of malignancy

British Journal of Cancer

Volumn 85, Issue 4, 2001, Pages 473-483

  O'Byrne, K J ^a   Dalgleish, A G ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiogenesis; Cancer; Cell mediated immunity; Humoral immunity

Indexed keywords

CARCINOGEN; CYCLOOXYGENASE 2; CYTOKINE; DNA; MALONALDEHYDE; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; APOPTOSIS; CANCER; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DNA DAMAGE; GENE MUTATION; HUMAN; HUMORAL IMMUNITY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS INFECTION; WART VIRUS;

CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; CYCLOOXYGENASE 2; CYTOKINES; HUMANS; INFLAMMATION; ISOENZYMES; MALONDIALDEHYDE; MEMBRANE PROTEINS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS;

EID: 0035902802     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1943     Document Type: Review

References (160)

1. Aspirin and risk of gastric cancer: A population-based case-control study in Sweden
2. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix
3. Ultraviolet B(UVB)-induced cox-2 expression in murine skin: An immunohistochemical study
4. Role of schistosomiasis in human bladder cancer: Evidence of association, aetiological factors, and basic mechanisms of carcinogenesis
5. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kB activation
6. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
7. Molecular pathobiology and immunology of malignant mesothelioma
8. Detection of Epstein-Barr Virus in Invasive Breast Cancers
9. Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia
10. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia II. Systemic but not local IgA responses correlate with clearance of HPV-16
11. Introduction and Historical perspective
12. Simian virus-40 large-T antigen binds p53 in human mesotheliomas
13. Regulation of cell death protease caspase-9 by phosphorylation
14. Non-steroidal anti-inflammatory drugs and bladder cancer prevention
15. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
16. Human papillomavirus detection by the hybrid capture II assay: A reliable test to select women with normal cervical smears at risk for developing cervical lesions
17. The Th1-Th2 hypothesis of HIV infection: New insights
18. Self-organization, complexity and chaos: The new biology for medicine
19. At the crossroads of inflammation and tumorigenesis
20. MMP-9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer
21. The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines
22. Viruses and cancer
23. The pathogenesis of AIDS: Classical and alternative views
24. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
25. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
26. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia
27. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
28. Differential effects of cyclo-oxygenase pathway metabolites on cytokine production by T lymphocytes
29. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells
30. Evasion of host immune responses by tumours and viruses
31. Cyclooxygenase in biology and disease
32. Acute bacterial prostatitis induces hematogenous dissemination of prostate epithelial cells
33. Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice
34. Prognostic factors for malignant mesothelioma in 142 patients: Validation of CALGB and EORTC prognostic scoring systems
35. Increased expression of cyclooxygenase-2 in rat lung tumours induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: The impact of a high-fat diet
36. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production
37. Possible role of lipid peroxidation in the induction of NF-kB and AP-1 in RFL-6 cells by crocidolite asbestos: Evidence following protection by vitamin E
38. Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres
39. EGFR induced activation of NF-kB in mesothelial cells by asbestos is important in cell survival
40. Renal cancer genetics: Von Hippel Lindau and other syndromes
41. Seminars in Medicine of the Beth Israel Hospital. Boston. Clinical applications of research on angiogenesis
42. Aspirin and reduced risk of esophageal carcinoma
43. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function
44. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice
45. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes
46. Natural history of HLA expression during tumour development
47. The contributions of cyclooxygenase-2 to tumor angiogenesis
48. Aspirin and the risk of colorectal cancer in women
49. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
50. Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation
51. Immune evasion of tumor cells using membrane-bound complement regulatory proteins
52. Tumor-mediated immunosuppression: Prevention by inhibitors of prostaglandin synthesis
53. Germ cell tumors of the testis overexpress wild-type p53
54. Does the HIV envelope induce a chronic graft-versus-host-like disease?
55. Reduction in cytokine production in colorectal cancer patients: Association with stage and reversal by resection
56. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs
57. Metaplastic polyp of the colon develops in response to inflammation
58. Immune activation in cervical neoplasia: Cross-sectional association between plasma soluble interleukin 2 receptor levels and disease
59. Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7
60. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma
61. Reproductive and infectious risk factors for invasive cervical cancer in Taiwan
62. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors
63. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation of interleukin 10 and down-regulation of interleukin 12 production
64. Profile of cytokine expression in nasopharyngeal carcinomas: A distinct expression of interleukin I in tumor and CD4+ T cells
65. A proinflammatory cytokine inhibits p53 tumor suppressor activity
66. Natural history of chronic hepatitis B and C
67. High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy
68. Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix
69. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus
70. Asbestos causes translocation of p65 protein and increases NF-kappaB DNA binding activity in rat lung epithelial and pleural mesothelial cells
71. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate
72. Analysis of IFN-gamma induced cell cycle arrest and cell death in hepatocytes
73. Polymerase chain reaction amplification of bacterial 16s rRNA genes in prostate biopsies from men without chronic prostatitis
74. Crohn's disease and colorectal malignancy
75. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction
76. Differences in angiogenic potential of classically vs alternatively activated macrophages
77. Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer
78. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors
79. Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice
80. Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database
81. HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes
82. T helper 2-dominant antilymphoma immune response is associated with fatal outcome
83. Genetic instabilities in human cancers
84. Cancer risk th patients with inflammatory bowel disease
85. Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue
86. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants
87. Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes
88. Epstein-Barr virus-dependent lymphoproliferative disease: Critical role of IL-6
89. Previous lung disease and risk of lung cancer among men and women nonsmokers
90. Esophageal cancers: Changing character, increasing incidence
91. Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells
92. Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms
93. Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer
94. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
95. Chronic mastitis and carcinoma of the breast
96. Tumour necrosis factor-a deficient mice are resistant to skin carcinogenesis
97. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
98. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma
99. Study of risk factors for prostatic cancer
100. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
101. Aspirin and the prevention of colorectal cancer: A review of the evidence
102. Immunomodulation by ultraviolet light: Clinical studies and biological effects
103. Immune selection in neoplasia: Towards a microevolutionary model of cancer development
104. UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival
105. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions
106. The influence of potential biases on the risk of breast tumors among women who received radiotherapy for acute postpartum mastitis
107. Consilience across evolving dysplasias affecting myeloid, cervical, esophageal, gastric and liver cells: Common themes and emerging patterns
108. T-cell abnormality and defective interleukin-2 production in patients with carcinoma of the urinary bladder with schistosomiasis
109. Ovarian cell differentiation: A cascade of multiple hormones, cellular signals, and regulated genes
110. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance
111. Nicotine stereoisomers and cotinine stimulate prostaglandin E2 but inhibit thromboxane B2 and leukotriene E4 synthesis in whole blood
112. Antiestrogens and breast cancer
113. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa
114. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice
115. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development
116. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo
117. Lymphocyte function in wound healing and following injury
118. Aspirin use and lung, colon, and breast cancer incidence in a prospective study
119. Augmented myocardial ischaemia by nicotine-mechanisms and their possible significance
120. Th1 cytokine patterns in cervical human papillomavirus infection
121. Cutaneous wound healing
122. Genetic susceptibility to tobacco carcinogenesis
123. Interrelation of lymphocyte subpopulations in peripheral blood under cervical papillomavirus infection
124. Immune evasion by tumours: Involvement of the CD95 (APO-I/Fas) system and its clinical implications
125. The American Cancer Society Prospective Study
126. Inhibition of cyclooxygenase: A novel approach to cancer prevention
127. Epstein-Barr virus and gastric carcinoma
128. Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or -2
129. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)
130. NF-kB: A lesson in family values
131. Aspirin use and reduced risk of fatal colon cancer
132. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
133. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines
134. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
135. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
136. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
137. Soluble interleukin 2 receptor levels and cervical neoplasia: Results from a population-based case-control study in Costa Rica
138. The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer
139. Apoptosis and proliferation of epithelial cells in papillomaviral and chlamydial cervicitis
140. Cyclo-oxygenase 2 and breast cancer prevention. Non-steroidal anti-inflammatory agents are worth testing in breast cancer
141. Cyclooxygenases 1 and 2
142. Tumour Vaccines
143. Genetic alterations during colorectal-tumor development
144. Normal pharmacologically-induced, but decreased regenerative liver growth in interleukin-6-deficient (IL-6-(-/-)) mice
145. Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan
146. Regulation of local host-mediated anti-tumor mechanisms by cytokines: Direct and indirect effects on leukocyte recruitment and angiogenesis
147. Human Immunodeficiency Viruses
148. Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-associated markers of immune dysfunction
149. Kaposi's sarcoma herpesvirus as a new paradigm for virus-induced oncogenesis
150. Inflammatory cell infiltrate in the cervix as a predictor of residual cervical intraepithelial neoplasia after conization
151. Helicobacter pylori: From the benign to the malignant
152. Expression of cyclooxygenase-2 in human lung carcinoma
153. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas
154. Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1
155. Regulation of cyclooxygenase-2 expression in renal medulla by tonicity in vivo and in vitro
156. Inhibition of COX-2 and induction of apoptosis: Two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis
157. Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells
158. Involvement of tyrosine kinases on cyclooxygenase expression and prostaglandin E2 production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor
159. HER-2/neu blocks tumour necrosis factor-induced apoptosis via the Akt/NF-kB pathway
160. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: Expression of the transforming BARF1 gene